Natural Biocon accepts resignation of CS Shruti Sharma effective Sep 26

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Shruti Sharma resigned as Company Secretary and Compliance Officer
  • Cessation effective September 26, 2026, after business hours
  • Reason cited: better growth and career opportunity
  • Filing complies with SEBI Regulation 30 and Schedule III
powered bylight_fuzz_icon
51974488

*this image is generated using AI for illustrative purposes only.

Natural Biocon (India) Limited has accepted the resignation of Shruti Sharma from her role as Company Secretary and Compliance Officer. The cessation is effective from September 26, 2026, following business hours.

Sharma cited better growth and career opportunity as the reason for stepping down from the Key Managerial Personnel position. She confirmed that no other material reasons influenced her decision to leave the company.

Regulatory compliance details

The intimation was filed with the BSE in compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing also adheres to Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The Managing Director, Arunkumar Dashrath Bhai Prajapati, signed the official communication to the Department of Corporate Services at BSE Ltd. The resignation letter was dated September 26, 2026, and requested immediate relief from duties.

Resignation specifics

Detail Information
Name Shruti Sharma
Role Company Secretary and Compliance Officer
Reason Better growth and career opportunity
Date of Cessation September 26, 2026
Membership No. A52723

The company stated that Sharma’s resignation was tendered via a letter dated September 26, 2026. She will be relieved from responsibilities after the closing of business hours on that same date. No appointment details or relationship disclosures were applicable as this is a cessation event.

Historical Stock Returns for Natural Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-3.51%-6.21%-13.96%-20.11%-47.75%-89.92%

Who has been appointed as the interim or permanent replacement for Shruti Sharma as Company Secretary and Compliance Officer?

How will Natural Biocon ensure seamless regulatory compliance and filing continuity during the transition period?

Does this leadership change signal broader organizational restructuring or strategic shifts within Natural Biocon?

Natural Biocon sets September 5 board meeting for AGM approvals

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Board meeting scheduled for September 5, 2026
  • Agenda includes ratification of EGM resolutions from May 2024
  • Approval of Director’s and Secretarial Audit Reports for FY26
  • Fixing of AGM date, venue, and book closure dates
powered bylight_fuzz_icon
49819861

*this image is generated using AI for illustrative purposes only.

Natural Biocon has scheduled a Board of Directors meeting for September 5, 2026. The session will focus on approving the Annual General Meeting (AGM) logistics and statutory reports for the fiscal year ended March 31, 2026.

The company issued the intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to take place at the company’s registered office in Ahmedabad.

Agenda Items

The board will consider and approve several key resolutions during the session. The primary agenda includes:

  • Ratification of resolutions passed at the Extraordinary General Meeting held on May 23, 2024.
  • Approval of the draft Director’s Report and Secretarial Audit Report for the year ended March 31, 2026.
  • Fixing the date, time, and venue for the Annual General Meeting.
  • Deciding on dates for the closure of the Register of Members and Share Transfer Register for the annual book closure.
  • Approving the draft notice for the AGM.
  • Appointing a scrutinizer for remote e-voting and voting at the AGM.

Arunkumar Prajapati, Managing Director, signed the communication addressed to the General Manager of the Corporation Relationship Department at BSE Limited.

Historical Stock Returns for Natural Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-3.51%-6.21%-13.96%-20.11%-47.75%-89.92%

What specific strategic initiatives or financial targets will be highlighted in the Director's Report for the fiscal year ended March 31, 2026?

How might the ratification of resolutions from the May 2024 Extraordinary General Meeting impact Natural Biocon's capital structure or operational governance?

Will the Secretarial Audit Report reveal any compliance discrepancies or governance improvements that could influence investor confidence?

More News on Natural Biocon

1 Year Returns:-47.75%